Clinical Trials Logo

Cancer, Thyroid clinical trials

View clinical trials related to Cancer, Thyroid.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05783323 Recruiting - Cancer Clinical Trials

Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer

Start date: February 14, 2024
Phase: Phase 2
Study type: Interventional

Papillary thyroid cancer (PTC) is the most common form of differentiated thyroid cancer (DTC). The traditional first line treatment for patients with advanced DTC after surgical resection is radioactive iodine (RAI) therapy. However, less than a quarter of patients with lung metastases will achieve a complete response to RAI therapy, and this therapy carries the risk of pulmonary fibrosis and an increasingly recognized risk of secondary malignancies.